Bellevue Life Sciences extends sponsor promissory notes maturity to Sept 30, 2025 regardless of business combination

OSR Holdings, Inc.

Second amendment removes earlier condition that notes matured on earlier of Sept 30, 2025 or business combination close.
Four promissory notes from sponsor Bellevue Global Life Sciences Investors, LLC aggregate $1.69M principal.
All other terms remain unchanged; notes are unsecured and governed by existing covenants.
Amendment executed January 23, 2025; previous amendment dated January 9, 2025 extended to Sept 30, 2025 or deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.